PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,533,766 | -22.9% | 241,919 | +12.7% | 0.00% | – |
Q1 2024 | $1,989,453 | -38.2% | 214,612 | -15.0% | 0.00% | -100.0% |
Q4 2023 | $3,218,278 | +177.4% | 252,414 | +124.8% | 0.00% | – |
Q3 2023 | $1,160,008 | -60.5% | 112,295 | -49.9% | 0.00% | -100.0% |
Q2 2023 | $2,936,325 | +72.8% | 223,976 | +47.3% | 0.00% | – |
Q1 2023 | $1,699,696 | -41.0% | 152,030 | -55.5% | 0.00% | -100.0% |
Q4 2022 | $2,879,047 | +25512.0% | 341,524 | -49.4% | 0.00% | -66.7% |
Q3 2022 | $11,241 | +73.1% | 674,734 | +53.0% | 0.00% | +50.0% |
Q2 2022 | $6,493 | -99.9% | 441,104 | -12.0% | 0.00% | -33.3% |
Q1 2022 | $12,430,000 | +267.5% | 501,022 | +375.1% | 0.00% | +200.0% |
Q4 2021 | $3,382,000 | -38.8% | 105,456 | -31.4% | 0.00% | 0.0% |
Q3 2021 | $5,530,000 | +33.2% | 153,704 | +63.4% | 0.00% | 0.0% |
Q2 2021 | $4,151,000 | +106.5% | 94,080 | +223.1% | 0.00% | 0.0% |
Q4 2020 | $2,010,000 | – | 29,118 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
Yu Fan | 303,030 | $13,861,000 | 36.18% |
ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
Miura Global Management | 405,000 | $18,525,000 | 3.31% |
GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |